FDA Inspection 1170339 — Reliance Life Sciences Private Limited

Reliance Life Sciences Private Limited — FEI 3009510975

The FDA completed an inspection of Reliance Life Sciences Private Limited on April 15, 2022 in Navi Mumbai. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 15, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Navi Mumbai (India)

Additional Details

Clinical BA/BE